Earlier studies reported beneficial effects of pharmacologic cyclophilin inhibition or genetic silencing of cyclophilin D in animal models of acute kidney injury or chronic kidney disorders, including CsA nephrotoxicity (35, 36, 37). Here, PPIB is linked to acute kidney injury.